Cargando…
MMP1 acts as a potential regulator of tumor progression and dedifferentiation in papillary thyroid cancer
Papillary thyroid cancer (PTC) is one of the malignancies with an excellent prognosis. However, in PTC, progression or dedifferentiation into poorly differentiated thyroid cancer (PDTC) or anaplastic thyroid cancer (ATC) extremely jeopardizes patients’ prognosis. MMP1 is a zinc-dependent endopeptida...
Autores principales: | Zhou, Jun, Xu, Ming, Tan, Jie, Zhou, Lin, Dong, Fang, Huang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720150/ https://www.ncbi.nlm.nih.gov/pubmed/36479070 http://dx.doi.org/10.3389/fonc.2022.1030590 |
Ejemplares similares
-
Case Report: Implantation of Dedifferentiated to Poorly Differentiated Thyroid Carcinoma After Endoscopic Thyroid Surgery
por: Hu, Jin, et al.
Publicado: (2022) -
Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer
por: Xu, Weibo, et al.
Publicado: (2021) -
TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer
por: Ma, Jun-Jie, et al.
Publicado: (2023) -
New Therapies for Dedifferentiated Papillary Thyroid Cancer
por: Fallahi, Poupak, et al.
Publicado: (2015) -
A systematic review and meta-analysis comparing tumor progression and complications between radiofrequency ablation and thyroidectomy for papillary thyroid carcinoma
por: Sun, Yuan-dong, et al.
Publicado: (2022)